# RECOVER:Comparison of Renal Toxicity Between Visipaque(Iodixanol)and Hexabrix(Ioxaglate)in Renal Insufficiency Undergoing Coronary Angiography

> **NCT00247325** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital**

## Conditions studied

- Kidney Failure

## Interventions

- **DRUG:** Iodixanol(Drug)

## Key facts

- **NCT ID:** NCT00247325
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** — (—)
- **Last updated:** 2006-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00247325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00247325, "RECOVER:Comparison of Renal Toxicity Between Visipaque(Iodixanol)and Hexabrix(Ioxaglate)in Renal Insufficiency Undergoing Coronary Angiography". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00247325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*